ConcertAI Releases CTO 2.0, a Next Generation AI SaaS Solution for Oncology Clinical Trial Design and Optimization

CAMBRIDGE, Mass., April 5, 2023 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life sciences and healthcare, today announced the release of its next generation of Clinical Trial Optimization…

Click here to view original post